Regeneron Pharmaceuticals Inc
REGN XNAS
$612.50
-0.56 (-0.09%)
▼
15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$63.95B
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.61B | $727.20M | $6.99 |
| FY 2025 | $14.34B | $4.50B | $43.07 |
| Q3 2025 | $3.75B | $1.46B | $14.09 |
| Q2 2025 | $3.68B | $1.39B | $13.24 |
TickerDaily Coverage
Why Is Apogee Therapeutics, Inc. Common Stock (APGE) Stock Up 46.8% Today?
Market News
Alex Chen · 22h ago
Apogee Therapeutics stock exploded 46.8% on Monday, June 22, 2026, reaching $132.66 as trading...
Why Are These 5 Stocks Making Huge Moves Before the Bell Today? June 1 Pre-Market Analysis
Market News
Sarah Mitchell · Jun 1, 2026
Five major stocks are trading sharply higher and lower in pre-market action Monday morning, driven...
Stock Market Today, May 5, 2026: Indexes Edge Higher on Earnings Optimism
Market News
Sarah Mitchell · May 5, 2026
U.S. stock indexes opened higher on Tuesday, May 5, 2026, as investors digested a wave of corporate...
Why Are Top Stocks Moving Before the Bell? Pre-Market Movers April 2, 2026
Market News
Sarah Mitchell · Apr 2, 2026
Thursday's pre-market session is showing significant movement across tech, healthcare, and...
Stock Market Today, March 27, 2026: Micro-Caps Dominate as Week Ends with 168% ARTL Surge
Market News
David Brooks · Mar 27, 2026
The week of March 23–27, 2026 belonged to micro-cap and small-cap names, with biotech and specialty...
View All Coverage →
Get REGN Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Regeneron Pharmaceuticals Inc.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.